Virax Biolabs is an innovative biotechnology company established in 2013 and based in the United Kingdom. The company's primary focus is on the detection of immune responses to and diagnosis of viral diseases. With a commitment to leveraging biotechnology in the healthcare and life sciences fields, Virax Biolabs has garnered attention from investors, culminating in a Post-IPO Equity investment on 21 August 2024. Although the specific investors for this round are not disclosed, this recent investment signifies a potential growth trajectory for the company in the burgeoning landscape of medical devices and biotechnology.
Virax Biolabs
Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.
Founded 2013
London, United Kingdom
27 employees
Post Ipo Equity
Biotechnology, Health Care +2
London, United Kingdom
27 employees
Post Ipo Equity
Biotechnology, Health Care +2
General Information
Get notified when Virax Biolabs moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Virax Biolabs
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Virax Biolabs
Taxonomy: Viral diseases, Immune response, In vitro diagnostic, T-Cell testing, COVID-19 diagnosis, Hepatitis B diagnosis, Malaria diagnosis, Human Papilloma Virus diagnosis, Biosensor technology, Point-of-care testing, Medical equipment, Technology, Medical device development
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | - | 21 Aug 2024 | |
| Post-IPO Equity | •••••• | - | 08 Mar 2023 | |
| Post-IPO Equity | •••••• | - | 04 Nov 2022 | |
| Series A | •••••• | - | 13 Mar 2020 | |
| Pre-Seed | •••••• | - | 24 Sep 2018 |
Virax Biolabs Alternatives & Competitors
Virax Biolabs vs
Craif Inc.
United States
Harnessing the power of urinary miRNA to detect cancer early
Non Equity Assistance
19 employees
AI, Health Care
Virax Biolabs vs
Virax Biolabs vs
Also compare with:
vs
KISSH
vs
KISSH
FAQ About Virax Biolabs
Innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases.
Virax Biolabs was founded in 2013.
Virax Biolabs is headquartered in London, United Kingdom.
Virax Biolabs operates in the following industries: Biotechnology, Health Care, Life Sciences, Medical Devices.
Virax Biolabs has approximately 27 employees.
Virax Biolabs has completed 7 funding rounds. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Virax Biolabs include Craif Inc., 南京普济生物有限公司, Valtari Bio, KISSH, Identifai Genetics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Virax Biolabs and Craif Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Virax Biolabs and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
